Costs
Automated blood culture tests are generally performed in centralised facilities with the infrastructure required to support large, costly instruments.
Not only are current machines very expensive items, they typically require extensive and costly ongoing maintenance contracts. Space and energy hungry, these instruments are not compatible with the current demands of the market.
Cost within the healthcare sector is clearly a major issue for healthcare professionals:
With low capital costs and no need for expensive service contracts, Bactest Gemini responds to the pressure to constrain costs. Further though, rapid detection of positive samples reduces the direct healthcare costs in terms of antibiotic usage, bed residency and clinician time. This is particularly true where time savings can be made with slow growing organisms.
This is particularly important in the context of localised testing eliminating transit time for blood samples with the inherent additional savings within the system.
Reduction of false positive and false negative results is key, not only to providing improved healthcare but cost savings too. Repeat tests are not required and patient residency and multiple consultancy reduced.
Gemini has been designed around the financial constraints of a broad range of laboratories. The problem has been attacked from a number of angles creating new concepts in the application of improved healthcare and consequently creating the opportunity for cost savings to be made in many ways – improved service to the patient truly can save money!!
Market Sectors
